These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 599703)

  • 1. [Studies on latex agglutination test for fibrin degradation products (author's transl)].
    Isobe J; Hamai Y; Taharaguchi T; Watanabe H; Kusumoto M; Saito S
    Rinsho Byori; 1977 Oct; 25(10):843-7. PubMed ID: 599703
    [No Abstract]   [Full Text] [Related]  

  • 2. [A new method for determination of DD/E complex using latex agglutination].
    Soe G; Kohno I; Motojima M; Saito M; Matsuda M; Terukina S
    Rinsho Byori; 1989 Apr; Spec No 81():176-82. PubMed ID: 2754805
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of a new anti-fibrinogen-coated latex particle agglutination test in the measurement of serum fibrin degradation products.
    Marder VJ; Cruz GO; Schumer BR
    Thromb Haemost; 1977 Apr; 37(2):183-91. PubMed ID: 577622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of fibrin degradation products on different biological tests (author's transl)].
    Vila V; Aznar J; Regañon E
    Sangre (Barc); 1976; 21(4):814-26. PubMed ID: 1006498
    [No Abstract]   [Full Text] [Related]  

  • 5. [Evaluation of a latex test for determining the fibrinogen/fibrin D-dimer (XDP)].
    Barsotti A; Savarino A
    Quad Sclavo Diagn; 1987 Dec; 23(4):421-4. PubMed ID: 3508302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical evaluation of a test for plasma fibrin/fibrinogen degradation products (FDP) based on monoclonal anti-FDP antibody technology: an application for the scoring system of the disseminated intravascular coagulation (DIC) diagnostic criteria].
    Ito K; Wada H; Abe Y; Tomatsu H; Nishioka J; Nobori T
    Rinsho Byori; 2003 Apr; 51(4):295-9. PubMed ID: 12747249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of 2 tests for determining lytic products of fibrin].
    Chalini-Carreon F; Ortiz-Méndez VM; Olvera-Hidalgo C; Magaña-Pérez JA
    Bol Med Hosp Infant Mex; 1983 Nov; 40(11):613-7. PubMed ID: 6651948
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of latex agglutination tests for fibrin-fibrinogen degradation products in the forensic identification of menstrual blood.
    Akutsu T; Watanabe K; Motani H; Iwase H; Sakurada K
    Leg Med (Tokyo); 2012 Jan; 14(1):51-4. PubMed ID: 22189168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Quantitative analysis of crosslinked fibrin degradation products (XDP) in several diseases].
    Saito M; Asakura H; Ito K; Joukaji H; Uotani C; Kumabashiri I; Matsuda T
    Rinsho Ketsueki; 1988 Nov; 29(11):2042-7. PubMed ID: 3236412
    [No Abstract]   [Full Text] [Related]  

  • 10. [Standarization of the staphylococcal clumping test (SCT) for the detection of fibrinogen/fibrin degradation products (FDP) in serum (author's transl)].
    Contreras P; Salazar R
    Rev Med Chil; 1975 Aug; 103(8):551-4. PubMed ID: 1197971
    [No Abstract]   [Full Text] [Related]  

  • 11. Assays for fibrinogen-fibrin degradation products in biological fluids: some methodological aspects.
    Donati MB
    Thromb Diath Haemorrh; 1975 Dec; 34(3):652-60. PubMed ID: 1108282
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of a direct latex-agglutination technic with the tanned red cell hemagglutination inhibition immunoassay (TRCHII) for semiquantitation of fibrinogen/fibrin degradation products.
    Wilson JE; Thornton RD
    Am J Clin Pathol; 1976 Apr; 65(4):528-32. PubMed ID: 1266814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of fibrin(ogen) degradation products in preeclampsia using immunoblot, enzyme-linked immunosorbent assay, and latex-based agglutination.
    Proietti AB; Johnson MJ; Proietti FA; Repke JT; Bell WR
    Obstet Gynecol; 1991 May; 77(5):696-700. PubMed ID: 2014082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of FDP].
    Ikematsu S; Kuroso K
    Rinsho Byori; 1985 Feb; Spec No 61():86-96. PubMed ID: 3889425
    [No Abstract]   [Full Text] [Related]  

  • 15. Automated latex agglutination and ELISA testing yield equivalent D-dimer results in patients with recent myocardial infarction. THROMBO Research Investigators.
    Marder VJ; Zareba W; Horan JT; Moss AJ; Kanouse JJ
    Thromb Haemost; 1999 Nov; 82(5):1412-6. PubMed ID: 10595629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prototype quantitative assay for fibrinogen/fibrin degradation products. Clinical evaluation.
    Sigal SH; Cembrowski GS; Shattil SJ; Brown NM; Schifreen RS; Schwartz MW
    Arch Intern Med; 1987 Oct; 147(10):1790-3. PubMed ID: 3662708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunochemical model for the agglutination reaction of FR antigens in a new latex photometric immunoassay with near infrared turbidimetry.
    Sudo T; Tsutsui S; Ito M; Morita S; Sawai M
    Kitasato Arch Exp Med; 1980 Jun; 53(1-2):55-68. PubMed ID: 7277958
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparisons of hemagglutination inhibition, staphylococcal clumping, and latex agglutination tests for canine fibrinolytic degradation products.
    Chen JP; Williams TK; Legendre AM
    Am J Vet Res; 1981 Dec; 42(12):2049-52. PubMed ID: 7340573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rebuttal of the article of Bounameaux et al.
    Smith M; Kortmann C
    Thromb Haemost; 1994 Sep; 72(3):488-90. PubMed ID: 7855805
    [No Abstract]   [Full Text] [Related]  

  • 20. [Detection of cross-linked fibrin degradation products by the latex agglutination method using monoclonal antibodies].
    Kuroso K; Arai M; Ikematsu S; Fujimaki M; Fukutake K
    Rinsho Byori; 1985 Dec; 33(12):1435-9. PubMed ID: 3831426
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.